BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Geron Corporation 

230 Constitution Drive

Menlo Park  California  94025  U.S.A.
Phone: 650-473-7700 Fax: 650-473-7750


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology


Collaborations

Intergen Company 





 Company News
Geron Corporation (GERN) Analyst Report: High Potential High Risk Biopharmaceutical Firm Seeking To Advance Novel Innovative Cancer Treatment For Myeloid Malignancies By BrokerBank Securities, Inc. 4/7/2014 9:47:36 AM    More...
Geron Corporation (GERN) Says FDA Halts Patient Enrollment In Another Cancer Trial 3/20/2014 7:29:54 AM    More...
Geron Corporation (GERN) Tanks As FDA Halts Development Of Blood Disorder Drug 3/12/2014 7:35:27 AM    More...
Geron Corporation (GERN) Soars After Study Shows Bone Marrow Drug's Benefit 12/6/2013 7:40:27 AM    More...
Researchers Note Cautions About Geron Corporation (GERN) Drug Imetelstat 11/11/2013 8:31:25 AM    More...
Geron Corporation (GERN) Skyrockets as Cancer Drug is Highly Effective in Trial, Shares Up +44.72% @ Market Close (November 7, 2013) 11/7/2013 8:30:43 AM    More...
Asterias Biotherapeutics, Inc., a Subsidiary of BioTime (BTX), Acquires Geron Corporation (GERN)’s Embryonic Stem Cell Assets 10/1/2013 10:51:31 AM    More...
BioTime (BTX) Signs Definitive Agreement With Geron Corporation (GERN) Regarding Stem Cell Assets 1/7/2013 10:09:04 AM    More...
Geron Corporation (GERN) Ends Brain Cancer Drug Study, Cuts 43 Jobs 12/4/2012 7:37:22 AM    More...
Ex-Geron Corporation (GERN) CEO Launches Effort to Revive Lost Stem Cell Program 10/25/2012 9:07:17 AM    More...
12345678910...